TIAF1 anticorps (AA 1-115)
Aperçu rapide pour TIAF1 anticorps (AA 1-115) (ABIN7171970)
Antigène
Voir toutes TIAF1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-115
-
Réactivité croisée
- Humain
-
Purification
- Antigen Affinity Purified
-
Immunogène
- Recombinant Human TGFB1-induced anti-apoptotic factor 1 protein (1-115AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TIAF1 (TGFB1-Induced Anti-Apoptotic Factor 1 (TIAF1))
-
Autre désignation
- TIAF1
-
Sujet
-
Background: Inhibits the cytotoxic effects of TNF-alpha and overexpressed TNF receptor adapters TRADD, FADD, and RIPK1. Involved in TGF-beta1 inhibition of IkappaB-alpha expression and suppression of TNF-mediated IkappaB-alpha degradation.
Aliases: TIAF1 antibody, TGFB1-induced anti-apoptotic factor 1 antibody, 12 kDa TGF-beta-1-induced antiapoptotic factor antibody
-
UniProt
- O95411
Antigène
-